The Technical AnalystExchange: EURONEXT Industry: Drug Manufacturers General
Virbac SA Price, Forecast, Insider, Ratings, Fundamentals & Signals
-1.39% €354.50
America/New_York / 17 mai 2024 @ 11:35
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2 967.07 mill |
| EPS: | 14.14 |
| P/E: | 25.07 |
| Earnings Date: | Mar 19, 2024 |
| SharesOutstanding: | 8.37 mill |
| Avg Daily Volume: | 0.0039 mill |
| RATING 2024-05-17 |
|---|
| A+ |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Neutral | |
| P/E: | Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/21 | 4/21 | 2/22 | 4/22 | 2/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | n/a | n/a | n/a | n/a | n/a | n/a |
| Asset | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt | n/a | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.42x |
| Company: PE 25.07 | sector: PE 17.68 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.40x |
| Company: PE 25.07 | industry: PE 17.94 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
€220.69 (-37.75%) €-133.81 |
| Date: 2024-05-19 |
| Expected Trading Range (DAY) |
|---|
|
€ 344.73 - 364.27 ( +/- 2.76%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | €354.50 (-1.39% ) |
| Volume | 0.0054 mill |
| Avg. Vol. | 0.0039 mill |
| % of Avg. Vol | 140.10 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For VIRP.PA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
VIRP.PA
Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.